NEW YORK, NY--(Marketwire - Jun 6, 2012) - TriMarkPublications.com cites in its newly published "U.S. Glucose Testing Markets" report that the U.S. glucose self-testing market will spike to over $7.4 billion by 2016. For more information, visit: http://www.trimarkpublications.com/u-s-glucose-testing-markets.
Glucose testing can be categorized into two main modalities: self-testing and professional testing. There are many more glucose tests performed in professional settings than in self-testing settings, but at a much lower cost per test. The U.S. professional glucose testing market is forecast to jump to $3.4 billion by 2016. Blood glucose testing strip sales comprise nearly 86% of the total North American blood glucose testing market.
The "U.S. Glucose Testing Markets" report covers:
- Diabetes mellitus
- Glucose oxidase (GOX)
- Glucose dehydrogenase (GDH)
- Glucose hexokinase
- Blood glucose biosensors
- Continuous glucose monitoring
- Non-invasive glucose monitoring
- Urine strips
- Ketone testing
- Needle destruciton devices
The "U.S. Glucose Testing Markets" report examines companies manufacturing glucose testing equipment and supplies for the U.S. market. Companies covered include: 77 Elektronika, Abaxis, Abbott, ACON, AgaMatrix, Alere, Allmedicus, Amedica Biotech, A. Menarini, Apex, Arkray, Bayer, B. Braun Melsungen, Beckman Coulter, Bionime, Bio-Rad, BioTex, Calisto, Cambridge Sensors, DexCom, Diagnostic Devices/Prodigy Diabetes Care, DiaSys, Echo Therapeutics, Entra Health Systems, Fora Care, Freedom Meditech, Genesis Health, GenExel-Sein, GlucoPlus, GluMetrics, GlySens, GlySure, Grove Instruments, Hainice, HemoCue, Home Diagnostics, Infopia, IN4, International Techidyne, Instrumentation Laboratory, i-Sens, Johnson & Johnson, Luminous, Medtronic, Nipro, Nova Biomedical, OrSense, Polymer Technology Systems, Radiometer, Roche, Siemens AG, Smiths Group, Stanbio Laboratory, TaiDoc Technology, Techno Medica, U.S. Diagnostics and VeraLight.
Detailed charts with sales forecasts and marketshare data are included. For more information, visit: http://www.trimarkpublications.com/u-s-glucose-testing-markets.
TriMarkPublications.com is a global leader in the biotechnology, healthcare and life sciences market research publishing. For more information, please visit http://www.trimarkpublications.com.
The statements contained in this news release that are forward-looking are based on current expectations that are subject to a number of uncertainties and risks, and actual results may differ materially.